Group 1 - The company will hold its first extraordinary general meeting of shareholders for 2026 on January 14, 2026, at 15:00 in Jinan, Shandong Province [5][33] - The voting for the meeting will be conducted through the Shanghai Stock Exchange's online voting system, with specific time slots for both trading and internet voting [3][4] - Shareholders must register to attend the meeting, with specific requirements for both individual and institutional shareholders [10][13][14] Group 2 - The company plans to engage in daily related transactions with its largest shareholder, Shandong Commercial Group Co., Ltd., in 2026, which includes providing or receiving services, purchasing or selling goods, and leasing properties [22][29] - The board of directors has approved the expected amount for these daily related transactions, which will be submitted for shareholder approval [23][24] - The company emphasizes that these transactions will not significantly depend on the related parties and will follow fair market principles [21][29]
鲁商福瑞达医药股份有限公司关于召开2026年第一次临时股东会的通知